| Description |
Europe’s largest commercial antibodies event designed for the world’s leading business and scientific leaders and dedicated to the future development of the antibodies market in Europe and beyond.
* Where the future of the antibody industry will be decided
Europe’s largest forum for the advancement of antibody discovery and development
* A content driven agenda tackling the industries biggest issues
The most impressive mix of expert speakers from global pharmaceutical companies, cutting edge biotechs, research organisations and academia
* Focused on bringing partners together
Build new relationships and future partnerships with more hours of dedicated networking than any other antibody event
Key speaker include
* Dr Alain Beck, Head of Physio-Chemistry Department, Centre d’Immunologie Pierre Fabre
* Dr Paul Parren, Senior Vice President, Research and Development, GenMab
* Dr Nils Lonberg, Senior Vice President and Scientific Director, Medarex
* Dr Janice Reichert, Senior Research Fellow, Tufts Center for the Study of Drug Development and Editor-in-Chief, mAbs
* Dr Nathalie Corvaïa, Head of Research, Centre d’Immunologie Pierre Fabre
* Dr Robert Lutz, Executive Director, ImmunoGen
* Dr Tony Maschio, Partner, Life Sciences and European Patent Attorney, Edwards, Angell, Palmer & Dodge LLP
* Professor Stefan Dübel, Director, Department of Biotechnology, University of Braunschweig, Germany
* Dr Iqbal Grewal, Vice President, Preclinical Therapeutics, Seattle Genetics
* Dr Eric Ezan, Head, Pharmacology and Immuanalytics, CEA
* Dr Stephen Demarest, Senior Scientist, Department of Protein Chemistry, Biogen Idec
* Dr Debbie Law, Chief Scientific Officer, Ablynx
Please visit the website for full programme and speaker details. www.terrapinn.com/2009/antibodyeu
|
|
